Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000597536 | SCV000706230 | uncertain significance | not provided | 2017-02-02 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001351588 | SCV001546078 | uncertain significance | Peroxisome biogenesis disorder, complementation group 7 | 2022-06-27 | criteria provided, single submitter | clinical testing | This variant, c.712_717dup, results in the insertion of 2 amino acid(s) of the PEX10 protein (p.Arg238_Leu239dup), but otherwise preserves the integrity of the reading frame. This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with PEX10-related conditions. ClinVar contains an entry for this variant (Variation ID: 500334). Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Natera, |
RCV001834896 | SCV002094119 | uncertain significance | Zellweger spectrum disorders | 2020-02-26 | no assertion criteria provided | clinical testing |